查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974194

外科海绵市场：依产品类型、材质、灭菌方法、应用、最终用户和销售管道划分－2026-2032年全球预测

Surgical Sponges Market by Product Type, Material, Sterilization Type, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外科海绵市场价值将达到 8.9127 亿美元，到 2026 年将成长至 9.6315 亿美元，到 2032 年将达到 15.0196 亿美元，年复合成长率为 7.74%。

主要市场统计数据
基准年 2025 8.9127亿美元
预计年份：2026年 9.6315亿美元
预测年份 2032 15.0196亿美元
复合年增长率 (%) 7.74%

对外科海绵的基本要素进行策略概述：重点关注其临床作用、供应链趋势、监管重点以及影响产品决策的创新压力。

手术海绵仍然是围手术全期护理的重要组成部分，在各个外科专科中发挥止血、伤口管理和手术安全保障的作用。手术室和门诊的广泛应用源于临床对可靠吸收剂的持续需求，这些吸收剂能够在各种生理条件下提供可预测的性能。同时，感染控制、抗生素使用和病人安全等领域的进步，使得通讯协定的审查日益严格，迫使製造商重新评估材料配方和灭菌方法。

重大的结构性变化正在改变整个围手术全期和门诊医疗保健环境中的供应商行为、临床偏好、消毒方法和分销模式。

近年来，外科海绵领域发生了翻天覆地的变化，其意义远不止于产品本身的改进。这些变化反映了医疗服务体系和风险管理的更广泛转变。首先，将感染预防要求纳入采购决策，使得抗菌处理海绵和检验的灭菌方法成为至关重要的采购标准。其次，医疗服务模式向门诊手术中心和门诊治疗室的转变改变了使用习惯，要求供应商调整包装尺寸、一次性使用规格和灭菌规范，以适应分散式医疗环境。

2025 年关税环境如何重塑外科海绵供应链的成本和连续性方面的供应链策略、采购决策和采购实务。

2025年推出并加强的医疗设备进口关税措施对整个外科海绵供应链的筹资策略、供应商选择和成本结构产生了累积影响。由于关税导致到岸成本增加，医疗器材采购部门和经销商被迫重新评估其供应商组合，尽可能优先考虑区域采购，并重新谈判长期合约以应对价格波动。在许多情况下，采购人员试图在成本压力和临床需求之间取得平衡，因此会转向那些在考虑关税和物流因素后，能够以更优惠的总交付成本提供同等临床性能的材料和供应商。

详细的細項分析表明，产品类型、材料、灭菌相容性、功能、应用、最终用户和通路对需求趋势的影响各不相同。

细分市场分析揭示了不同产品类型、材料、功能、灭菌方法、应用、最终用户和销售管道的性能预期和采购行为存在差异。在产品类型方面，复合材料结构通常定位于高性能应用，优先考虑吸水性、强度和保持/检测性能；而非不织布布则优先考虑一次性使用、生产稳定性和成本效益。由于传统偏好和重视传统纤维特性的特定临床细分市场，机织织物的需求依然强劲。材料选择进一步区分了产品。棉花因其天然的吸水性和柔软触感而备受青睐，而聚酯和聚丙烯等合成基材则因其稳定的生产公差、快速大规模生产的潜力以及与特定灭菌方法的兼容性而被选中。

区域比较分析揭示了美洲、欧洲、中东和非洲以及亚太地区的基础设施、法规和采购模式如何以不同的方式驱动临床和商业性优先事项。

区域趋势反映了不同的营运重点和基础设施能力，这些因素影响部署模式和策略规划。在美洲，对临床性能和基于价值的采购的关注推动了对先进功能和即用型无菌包装的需求。同时，分销网络和国内灭菌能力支援大型医疗保健系统快速响应。在欧洲、中东和非洲，情况较为复杂，有些地区的监管协调与其他地区的产能限制并存。这导致对支援多种灭菌途径且拥有完善供应链文件的产品需求不断增长。

竞争对手的行为和策略重点透过创新、伙伴关係和品质体系，将领导企业、细分领域专家和区域参与者区分开来。

在企业层面，发展趋势的特征是创新、供应链韧性和不同的商业化策略。主要企业正将研发重点放在改进材料科学、整合抗菌剂以及开发便于追溯和灭菌验证的包装系统。同时，中型企业和新兴企业通常凭藉其专业技术、区域伙伴关係关係或能够快速回应灭菌方法要求和终端用户偏好的灵活生产系统展开竞争。在法规环境下，为了降低供应连续性风险并加速市场准入，与灭菌服务供应商、分销网络和临床合作伙伴建立策略合作伙伴关係正变得越来越普遍。

为製造商和供应商提供可操作且优先的行动方案，以提高临床适用性、供应弹性、监管准备和跨通路商业性可行性。

产业领导者应采取一系列平衡的倡议，以提高临床可靠性、确保供应连续性并优化商业性覆盖范围。优先考虑能够显着提升临床操作和残留物检测能力的材料和设计创新，将有助于实现显着差异化，同时确保与多种灭菌方法相容，并扩大产品在各类医疗机构中的应用。加强与灭菌服务供应商和区域分销商的合作关係，将减少对长途跨境物流的依赖，并提高应对关税和物流因素造成的干扰的应对力。

我们将以透明的方式解释我们多方面的调查方法，该方法结合了相关人员访谈、监管审查和产品比较分析，以确保获得扎实的实践知识。

本研究整合了多种资料收集方法，旨在建立严谨的证据基础，同时保持研究限制和假设的透明度。主要调查包括对临床相关人员、采购经理、灭菌服务供应商和分销合作伙伴进行结构化访谈，以了解使用模式、采购因素以及对灭菌相容性的担忧。次要调查则查阅了监管指南、临床实践建议、灭菌标准和供应商技术文檔，并透过三角验证法对研究结果进行验证，以检验产品性能声明。

简明扼要地整合了不断发展的行业优先事项，展示了临床要求、灭菌相容性和供应弹性如何融合併定义竞争优势。

总之，在临床安全优先事项、灭菌需求和供应链现实的驱动下，外科海绵市场正处于可操作的创新和营运调整阶段。价值链上的各个相关人员都在积极回应，优先选择兼具检验的性能、灭菌柔软性和供应稳定性的产品。关税和物流压力正在加速在地化和多元化策略的实施，而终端用户向门诊护理的转变则促使包装、SKU和分销通路策略进行重组。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科海绵市场：依产品类型划分

  • 复合材料
  • 不织布
  • 织物

第九章 外科海绵市场：依材料分类

  • 棉布
  • 合成纤维
    • 聚酯纤维
    • 聚丙烯

第十章：以灭菌方法分類的外科海绵市场

  • 环氧乙烷
  • 伽玛射线灭菌
  • 蒸气
    • 干热灭菌
    • 湿热

第十一章 外科海绵市场：依应用领域划分

  • 牙科
  • 外科
  • 创伤护理

第十二章 外科海绵市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院
    • 私人的
    • 民众

第十三章 外科海绵市场：依销售管道划分

  • 直销
  • 批发商
    • 医疗设备批发商
    • 药品批发商
  • 电子商务
  • 零售药房

第十四章 外科海绵市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 外科海绵市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 外科海绵市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国外科海绵市场

第十八章：中国外科海绵市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Aspen Surgical Products
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • BSN medical GmbH
  • Cardinal Health, Inc.
  • ConvaTec Group Plc
  • Crosstex International, Inc
  • DeRoyal Industries, Inc.
  • Dynarex Corporation
  • Hollister Incorporated
  • Johnson & Johnson
  • Lohmann & Rauscher International GmbH & Co. KG
  • McKesson Corporation
  • Medline Industries, LP
  • Molnlycke Health Care AB
  • Owens & Minor, Inc.
  • Paul Hartmann AG
  • Smith & Nephew plc
  • Teleflex Incorporated
  • Winner Medical Co., Ltd.
  • Zhende Medical Co., Ltd.
Product Code: MRR-D97D8E0B50C0

The Surgical Sponges Market was valued at USD 891.27 million in 2025 and is projected to grow to USD 963.15 million in 2026, with a CAGR of 7.74%, reaching USD 1,501.96 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 891.27 million
Estimated Year [2026] USD 963.15 million
Forecast Year [2032] USD 1,501.96 million
CAGR (%) 7.74%

A strategic overview of surgical sponge fundamentals highlighting clinical roles, supply chain dynamics, regulatory focus, and innovation pressures shaping product decisions

Surgical sponges remain a fundamental component of perioperative care, supporting hemostasis, wound management, and procedural safety across surgical specialties. Their ubiquity in operating rooms and ambulatory settings is underpinned by continued clinical demand for reliable absorbent materials that perform predictably under diverse physiological conditions. In parallel, the evolving landscape of infection prevention, antimicrobial stewardship, and patient safety initiatives has raised scrutiny on product performance specifications and traceability protocols, driving manufacturers to re-evaluate material formulation and sterilization practices.

Supply chain complexity has intensified the need for resilient procurement strategies. Raw material sourcing, sterilization capacity, and distribution logistics influence availability and lead times in ways that extend beyond traditional procurement cycles. Regulatory agencies have increased the emphasis on device classification, labeling accuracy, and post-market surveillance, prompting stakeholders to align product design and quality systems with stricter compliance expectations. Consequently, innovation in product functionality, from antimicrobial treatments to advanced nonwoven constructions, is increasingly judged not only by clinical efficacy but also by manufacturability, sterilization compatibility, and supply continuity.

Major structural changes transforming supplier behavior, clinical preferences, sterilization practices, and distribution models across perioperative and outpatient care environments

Recent years have witnessed transformative shifts in the surgical sponge landscape that transcend incremental product changes and instead reflect broader shifts in healthcare delivery and risk management. First, the integration of infection-prevention imperatives into procurement decisions has elevated antimicrobial-treated sponges and validated sterilization pathways as decisive purchase criteria. Second, care migration toward ambulatory surgical centers and outpatient procedural suites has altered usage patterns, with suppliers adapting packaging sizes, single-use formats, and sterilization-ready configurations for decentralized settings.

Third, materials science advances have enabled hybrid constructions that balance absorbency, tensile strength, and visual contrast for retention detection. At the same time, concerns about supply chain resilience and regional sterilization capacity have incentivized manufacturers to localize certain production and sterilization steps, thereby shortening lead times and reducing cross-border risk. Moreover, regulatory scrutiny on labeling and traceability has prompted the adoption of enhanced tracking and documentation practices, which are increasingly incorporated into product development roadmaps. Collectively, these shifts are recalibrating how suppliers compete and collaborate with healthcare providers to meet operational efficiency and patient safety objectives.

How the 2025 tariff environment reshaped supply chain strategies, sourcing decisions, and procurement practices for cost and continuity in surgical sponge supply chains

The introduction and escalation of tariff measures in 2025 affecting medical device imports have had a cumulative impact on procurement strategies, supplier selection, and cost structures within the surgical sponge ecosystem. Tariff-driven increases in landed costs have compelled healthcare purchasers and distributors to reassess supplier portfolios, prioritize local or regional sourcing options where available, and renegotiate long-term agreements to absorb price volatility. In many instances, buyers have sought to balance cost pressures with clinical requirements by shifting toward materials or suppliers that offer similar clinical performance but more favorable total delivered costs when tariffs and logistics are considered.

Manufacturers with global supply chains have responded by diversifying raw material procurement, relocating elements of production closer to core markets, or investing in domestic sterilization capacity to mitigate tariff exposure. These adaptations have required capital allocation decisions and operational reconfiguration, particularly for companies that previously relied on fully integrated, cross-border supply chains. From the provider perspective, inventory management practices have evolved to include tariff risk as an explicit factor, prompting larger buffer inventories of critical items in certain contexts while accelerating adoption of standardized SKUs and consolidated sourcing to simplify customs and compliance.

In-depth segmentation perspectives exposing how product types, materials, sterilization compatibility, functionality, applications, end users, and channels differently influence demand dynamics

Segmentation insights reveal distinct performance expectations and procurement behaviors across product types, materials, functionality, sterilization methods, applications, end users, and sales channels. Within product type, composite constructions are frequently positioned for higher-performance applications where absorbency, strength, and retention-detection are prioritized, while nonwoven options emphasize disposability, consistent manufacturing, and cost efficiency; woven varieties continue to serve legacy preferences and specific clinical niches that value traditional textile properties. Material choices further differentiate offerings: cotton remains valued for natural absorbency and tactile properties, whereas synthetic substrates such as polyester and polypropylene are selected for consistent manufacturing tolerances, rapid scale-up potential, and compatibility with certain sterilization modalities.

Functionality segmentation underscores an increasing tilt toward antimicrobial treated sponges for high-risk procedures, with chlorhexidine-based and silver ion technologies deployed depending on compatibility with both tissue contact profiles and sterilization temperatures. Sterilization type considerations are central to product design, as ethylene oxide, gamma irradiation, and steam sterilization impose distinct material constraints; within steam sterilization, dry heat and moist heat variations influence sterilization validation and packaging choices. Application perspectives differentiate dental, surgical, and wound care usages, each demanding tailored size, absorbency, and handling features. End-user segmentation spans ambulatory surgical centers, clinics, and hospitals, with private and public hospital settings exhibiting different procurement cycles, tendering practices, and compliance requirements. Finally, sales channel distinctions highlight that direct contracts, distributor partnerships with medical or pharmaceutical wholesalers, ecommerce platforms, and retail pharmacies each present unique logistical and regulatory considerations that shape product configuration and commercial strategy.

A comparative regional analysis revealing how infrastructure, regulation, and procurement models in the Americas, Europe Middle East Africa, and Asia Pacific drive distinct clinical and commercial priorities

Regional dynamics display divergent operational priorities and infrastructure capacities that influence adoption patterns and strategic planning. In the Americas, emphasis on clinical performance and value-based procurement has spurred interest in advanced functionality and sterilization-ready packaging, while distribution networks and domestic sterilization capacity support faster response cycles for large health systems. Meanwhile, Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization in some jurisdictions coexists with capacity constraints in others, driving demand for products that accommodate multiple sterilization pathways and robust supply chain documentation.

Asia-Pacific exhibits significant variability between mature healthcare markets that pursue clinical innovation and rapidly developing systems focused on scaling access and cost efficiency. In many regional contexts, localization of manufacturing and partnerships with regional distributors have been effective strategies to address tariff exposure, local regulatory nuances, and logistics complexity. Across all regions, the interplay between regulatory expectations, sterilization infrastructure, and procurement models shapes both product design and go-to-market approaches, creating region-specific opportunity windows for manufacturers and suppliers who can align operational capabilities with local clinical and compliance needs.

Competitive company behaviors and strategic priorities that differentiate leaders, niche specialists, and regional players through innovation, partnerships, and quality systems

Company-level dynamics are characterized by differential approaches to innovation, supply chain resilience, and commercialization. Leading manufacturers focus R&D on material science improvements, antimicrobial integrations, and packaging systems that facilitate traceability and sterilization validation. At the same time, midsize and emerging players often compete through niche specialization, regional partnerships, or flexible manufacturing that can rapidly adapt to sterilization method requirements or end-user preferences. Strategic alliances with sterilization service providers, distribution networks, and clinical partners are increasingly common as companies seek to de-risk supply continuity and accelerate market access in regulated environments.

Commercial strategies vary, with some organizations prioritizing direct contracting and integrated services for large health systems, and others leveraging distributor networks and ecommerce channels to reach ambulatory and retail end users. Investment in quality management systems, regulatory affairs capabilities, and post-market surveillance infrastructure remains a differentiator, particularly in jurisdictions with evolving regulatory frameworks. Ultimately, competitive positioning is shaped by the ability to align product performance claims with validated sterilization compatibility, consistent supply, and robust documentation that supports clinical acceptance and procurement approval.

Practical and prioritized actions for manufacturers and suppliers to boost clinical alignment, supply resilience, regulatory readiness, and commercial execution across channels

Industry leaders should pursue a balanced set of actions that enhance clinical credibility, secure supply continuity, and optimize commercial reach. Prioritizing material and design innovations that demonstrably improve clinical handling and retention detection will create meaningful differentiation, while simultaneously ensuring compatibility with multiple sterilization modalities to broaden adoption across facility types. Strengthening relationships with sterilization service providers and regional distributors can reduce reliance on long cross-border flows and improve responsiveness to tariff- and logistics-driven disruptions.

Operationally, companies should enhance transparency and traceability across the supply chain to support tenders and regulatory inquiries, and they should invest in quality and regulatory affairs resources to smooth market access in diverse jurisdictions. Commercially, segment-specific go-to-market strategies that address the distinct needs of ambulatory centers, clinics, and hospital procurement committees will improve conversion and retention. Finally, establishing flexible packaging, SKU rationalization, and digital ordering capabilities can reduce complexity for procurement teams and support rapid fulfillment in decentralized care settings.

Transparent explanation of the multi-method research approach combining stakeholder interviews, regulatory review, and comparative product analysis to ensure robust and actionable insights

This research synthesis integrates multiple data-gathering methods to produce a rigorous evidence base while maintaining transparency about limitations and assumptions. Primary research included structured interviews with clinician stakeholders, procurement leaders, sterilization service providers, and distribution partners to capture usage patterns, procurement drivers, and sterilization compatibility concerns. Secondary research involved reviewing regulatory guidance, clinical practice advisories, sterilization standards, and supplier technical documentation to triangulate findings and validate product performance claims.

Analytical methods combined qualitative synthesis with comparative assessments of product features, sterilization compatibility, and commercial strategies. Where applicable, case examples and aggregated insights were used to illustrate common operational responses to supply chain disruptions, tariff impacts, and regional capacity constraints. Throughout, data integrity was prioritized by sourcing from regulatory and clinical literature, validated supplier specifications, and direct stakeholder testimonies. Limitations include variability in regional reporting standards and the evolving nature of regulatory guidance, which readers should consider when applying insights to local contexts.

Concise synthesis of the sector's evolving priorities showing how clinical requirements, sterilization compatibility, and supply resilience converge to define competitive advantage

In conclusion, the surgical sponge landscape is undergoing a period of pragmatic innovation and operational recalibration driven by clinical safety priorities, sterilization requirements, and supply chain realities. Stakeholders across the value chain are responding by prioritizing products that marry validated performance with sterilization flexibility and supply continuity. Tariff and logistics pressures have accelerated localization and diversification strategies, while end-user shifts toward ambulatory care have reframed packaging, SKU, and channel strategies.

Success in this environment will depend on the ability of manufacturers and suppliers to align technical claims with sterilization validations, to invest in resilient supply chain architectures, and to tailor commercial approaches to the needs of distinct end users and regions. For purchasers, the emphasis will increasingly be on documented performance, traceability, and reliable fulfillment. Taken together, these dynamics point toward a maturing sector where clinical, operational, and commercial priorities converge to define long-term competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Sponges Market, by Product Type

  • 8.1. Composite
  • 8.2. Nonwoven
  • 8.3. Woven

9. Surgical Sponges Market, by Material

  • 9.1. Cotton
  • 9.2. Synthetic
    • 9.2.1. Polyester
    • 9.2.2. Polypropylene

10. Surgical Sponges Market, by Sterilization Type

  • 10.1. Ethylene Oxide
  • 10.2. Gamma
  • 10.3. Steam
    • 10.3.1. Dry Heat
    • 10.3.2. Moist Heat

11. Surgical Sponges Market, by Application

  • 11.1. Dental
  • 11.2. Surgical
  • 11.3. Wound Care

12. Surgical Sponges Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals
    • 12.3.1. Private
    • 12.3.2. Public

13. Surgical Sponges Market, by Sales Channel

  • 13.1. Direct
  • 13.2. Distributors
    • 13.2.1. Medical Distributors
    • 13.2.2. Pharmaceutical Wholesalers
  • 13.3. Ecommerce
  • 13.4. Retail Pharmacies

14. Surgical Sponges Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Surgical Sponges Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Surgical Sponges Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Surgical Sponges Market

18. China Surgical Sponges Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Aspen Surgical Products
  • 19.7. B. Braun Melsungen AG
  • 19.8. Baxter International Inc.
  • 19.9. BSN medical GmbH
  • 19.10. Cardinal Health, Inc.
  • 19.11. ConvaTec Group Plc
  • 19.12. Crosstex International, Inc
  • 19.13. DeRoyal Industries, Inc.
  • 19.14. Dynarex Corporation
  • 19.15. Hollister Incorporated
  • 19.16. Johnson & Johnson
  • 19.17. Lohmann & Rauscher International GmbH & Co. KG
  • 19.18. McKesson Corporation
  • 19.19. Medline Industries, L.P.
  • 19.20. Molnlycke Health Care AB
  • 19.21. Owens & Minor, Inc.
  • 19.22. Paul Hartmann AG
  • 19.23. Smith & Nephew plc
  • 19.24. Teleflex Incorporated
  • 19.25. Winner Medical Co., Ltd.
  • 19.26. Zhende Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL SPONGES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL SPONGES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL SPONGES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL SPONGES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL SPONGES MARKET SIZE, BY NONWOVEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL SPONGES MARKET SIZE, BY NONWOVEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SPONGES MARKET SIZE, BY NONWOVEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOVEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOVEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOVEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COTTON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COTTON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL SPONGES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STEAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STEAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STEAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DRY HEAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DRY HEAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DRY HEAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MOIST HEAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MOIST HEAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MOIST HEAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOUND CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL SPONGES MARKET SIZE, BY WOUND CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL SPONGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL SPONGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL SPONGES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL SPONGES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL SPONGES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL SPONGES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DIRECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DIRECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL SPONGES MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PHARMACEUTICAL WHOLESALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PHARMACEUTICAL WHOLESALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL SPONGES MARKET SIZE, BY PHARMACEUTICAL WHOLESALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL SPONGES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL SPONGES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL SPONGES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL SPONGES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL SPONGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS SURGICAL SPONGES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL SPONGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. GCC SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 195. GCC SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 197. GCC SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. GCC SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GCC SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 227. G7 SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 228. G7 SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 230. G7 SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. G7 SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. G7 SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. NATO SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 239. NATO SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 241. NATO SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. NATO SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 245. NATO SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL SPONGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA SURGICAL SPONGES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA SURGICAL SPONGES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA SURGICAL SPONGES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA SURGICAL SPONGES MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA SURGICAL SPONGES MARKET SIZE, BY STERILIZATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA SURGICAL SPONGES MARKET SIZE, BY STEAM, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA SURGICAL SPONGES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA SURGICAL SPONGES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA SURGICAL SPONGES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA SURGICAL SPONGES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA SURGICAL SPONGES MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)